Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 4, 1997, Pages 369-373

  Van De Meeberg, P C ^a   Houwen, R H J ^b   Sinaasappel, M ^b   Heijerman, H G M ^b   Bijleveld, Ch M A ^b   Vanberge Henegouwen, G P ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

cholestasis; cystic fibrosis; liver disease; ursodeoxycholic acid

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030989703     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709007686     Document Type: Article

References (24)

1. O'Brien S, Fitzgerald MX, Hegarty JE. A controlled trial of ursodeoxycholic acid treatment in cystic fibrosis-related liver disease. Eur J Gastroenterol Hepatol 1992;4:857-63.
2. Bittner P, Posselt HG, Sailer T, Ott H, Magdorf K, Wahn U, et al. The effect of treatment with ursodeoxycholic acid in cystic fibrosis and hepatopathy: a placebo controlled study. In: Paumgartner G, Stiehl A, Gerok W, editors. Bile acids as therapeutic agents: from basic science to clinical practice. Dordrecht: Kluwer Academic Publishers, 1991:345-8.
3. Merli M, Bertasi S, Servi R, Diamanti S, Martino F, De Santis A, et al. Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial. J Pediatr Gastroenterol Nutr 1994;19:198-203.
4. Cotting J, Lentze MJ, Reichen J. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut 1990;31:918-21.
5. Colombo C, Setchell KDR, Podda M, Crosignani A, Roda A, Curcio L, et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr 1990;117:482-9.
6. Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology 1992;16:924-30.
7. Cotting J, Dufour JF, Lentze MJ, Paumgartner G, Reichen J. Ursodeoxycholate in the treatment of cholestasis in cystic fibrosis - a 2-year experience and review of the literature. In: Lentze MJ, Reichen J, editors. Pediatric cholestasis: novel approaches to treatment. Dordrecht: Kluwer Academic Publishers, 1992: 345-53.
8. Galabert C, Montet JC, Lengrand D, Lecuire A, Sotta C, Figarella C, et al. Effects of ursodeoxycholic acid on liver function in cystic fibrosis and chronic cholestasis. J Pediatr 1992;121:138-41.
9. Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A, Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. Hepatology 1996;23:1484-90.
10. Nakagawa M, Colombo C, Setchell KDR. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 1990;12:322-34.
11. Weber AM, Roy CC, Morin CL, Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 1973; 289:1001-5.
12. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-41.
13. Lacerda MA, Lindor KD, Jorgensen RA, Rossi S, Hofmann A, Dickson ER. Ursodiol therapy in primary biliary cirrhosis (PBC): enrichment correlates with biochemical improvement. Gastroenterology 1993;104:A933.
14. Jorgensen RA, Dickson ER, Hofmann AF, Rossi SS, Lindor KD. Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut 1995;36:935-8.
15. Van de Meeberg PC, Wolfhagen FHJ, VanBerge-Henegouwen GP, Salemans JMJI, Tangerman A, Van Buuren HR, et al. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: relation with biliary enrichment and biochemical response. J Hepatol. In press.
16. Van de Meeberg PC, Van Erpecum KJ, VanBerge-Henegouwen GP. Therapy with ursodeoxycholic acid in cholestatic liver disease. Scand J Gastroenterol 1993;28 Suppl 200:15-20.
17. Colombo C, Castellani MR, Balistreri WF, Seregni E, Assaisso ML, Giunta A. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 1992;15:677-84.
18. Jazrawi RP, de Caestecker JS, Goggin PM, Britten AJ, Joseph AEA, Maxwell JD, et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994;106:134-42.
19. Lacaille F, Paradis K, Lenaerts C, Sénéchal L, Lepage G, Roy CC, et al. Ursodeoxycholic acid (UDCA) improves essential fatty acid (EFA) deficiency in cystic fibrosis. Hepatology 1993; 18:271A.
20. Poupon RE, Poupon R, Balkau B, UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-7.
21. Floreani A, Zappala F, Mazzetto M, Naccarato R, Plebani M, Chiaramonte M. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. Dig Dis Sci 1994;39:9-14.
22. Kneppelhout JC, Mulder CJJ, VanBerge-Henegouwen GP, de Vries RA, Brandt KH. Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease. Neth J Med 1992;41:11-6.
23. Hwang SJ, Chan CY, Lee SD. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with a long-term follow-up. J Gastroenterol Hepatol 1993;8:217-23.
24. Vogel W, Kathrein H, Judmaier G, Braunsteiner H. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid. Lancet 1988;1:1163.